Kenzo Takada

11.4k total citations
158 papers, 9.3k citations indexed

About

Kenzo Takada is a scholar working on Oncology, Pathology and Forensic Medicine and Immunology. According to data from OpenAlex, Kenzo Takada has authored 158 papers receiving a total of 9.3k indexed citations (citations by other indexed papers that have themselves been cited), including 129 papers in Oncology, 55 papers in Pathology and Forensic Medicine and 52 papers in Immunology. Recurrent topics in Kenzo Takada's work include Viral-associated cancers and disorders (127 papers), Lymphoma Diagnosis and Treatment (55 papers) and Parvovirus B19 Infection Studies (40 papers). Kenzo Takada is often cited by papers focused on Viral-associated cancers and disorders (127 papers), Lymphoma Diagnosis and Treatment (55 papers) and Parvovirus B19 Infection Studies (40 papers). Kenzo Takada collaborates with scholars based in Japan, United States and Taiwan. Kenzo Takada's co-authors include Dai Iwakiri, Yasushi Ono, Norio Shimizu, Seiji Maruo, Teru Kanda, Shosuke Imai, Mrinal Samanta, Jun Nishikawa, Jun Komano and Tetsuo Ushiku and has published in prestigious journals such as Proceedings of the National Academy of Sciences, The Lancet and Journal of Biological Chemistry.

In The Last Decade

Kenzo Takada

156 papers receiving 9.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Kenzo Takada Japan 56 6.6k 2.7k 2.6k 2.2k 2.2k 158 9.3k
Gerald Niedobitek Germany 63 7.8k 1.2× 3.3k 1.2× 4.2k 1.6× 2.2k 1.0× 1.4k 0.6× 205 11.5k
Henri‐Jacques Delecluse Germany 55 6.8k 1.0× 2.0k 0.8× 3.2k 1.2× 2.9k 1.3× 1.5k 0.7× 153 8.9k
David A. Thorley‐Lawson United States 59 8.1k 1.2× 3.6k 1.3× 3.7k 1.4× 3.6k 1.6× 2.4k 1.1× 115 12.2k
Riccardo Dolcetti Italy 48 4.8k 0.7× 2.1k 0.8× 3.2k 1.2× 1.4k 0.6× 1.6k 0.7× 255 8.3k
Shannon C. Kenney United States 56 6.6k 1.0× 2.3k 0.9× 2.2k 0.8× 3.1k 1.4× 1.6k 0.7× 145 8.5k
Nancy Raab‐Traub United States 71 11.1k 1.7× 3.0k 1.1× 4.4k 1.7× 3.4k 1.5× 3.5k 1.6× 167 15.0k
Erle S. Robertson United States 57 6.4k 1.0× 1.4k 0.5× 2.1k 0.8× 4.0k 1.8× 2.8k 1.3× 226 9.3k
Blossom Damania United States 52 5.0k 0.8× 2.9k 1.1× 1.2k 0.5× 3.7k 1.7× 2.9k 1.3× 188 9.2k
Pierre Busson France 43 3.7k 0.6× 1.9k 0.7× 1.1k 0.4× 794 0.4× 2.4k 1.1× 124 6.4k
Margaret L. Gulley United States 44 4.1k 0.6× 936 0.3× 2.2k 0.9× 1.2k 0.5× 1.1k 0.5× 161 6.3k

Countries citing papers authored by Kenzo Takada

Since Specialization
Citations

This map shows the geographic impact of Kenzo Takada's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kenzo Takada with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kenzo Takada more than expected).

Fields of papers citing papers by Kenzo Takada

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kenzo Takada. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kenzo Takada. The network helps show where Kenzo Takada may publish in the future.

Co-authorship network of co-authors of Kenzo Takada

This figure shows the co-authorship network connecting the top 25 collaborators of Kenzo Takada. A scholar is included among the top collaborators of Kenzo Takada based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kenzo Takada. Kenzo Takada is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Wang, Dengli, Daiki Ousaka, Ziyi Wang, et al.. (2022). Treatment of Marmoset Intracerebral Hemorrhage with Humanized Anti-HMGB1 mAb. Cells. 11(19). 2970–2970. 4 indexed citations
2.
Takada, Kenzo. (2012). Evec, bio-venture for development of antibody therapeutics. Drug Delivery System. 27(1). 40–46.
3.
Katsumura, Koichi R., Seiji Maruo, & Kenzo Takada. (2012). EBV lytic infection enhances transformation of B‐lymphocytes infected with EBV in the presence of T‐lymphocytes. Journal of Medical Virology. 84(3). 504–510. 30 indexed citations
4.
Lee, Chung‐Pei, Jen‐Yang Chen, Su‐Fang Lin, et al.. (2012). Epstein-Barr Virus BGLF4 Kinase Retards Cellular S-Phase Progression and Induces Chromosomal Abnormality. PLoS ONE. 7(6). e39217–e39217. 52 indexed citations
5.
Matsusaka, Keisuke, Atsushi Kaneda, Genta Nagae, et al.. (2011). Classification of Epstein–Barr Virus–Positive Gastric Cancers by Definition of DNA Methylation Epigenotypes. Cancer Research. 71(23). 7187–7197. 183 indexed citations
7.
Matsumoto, Takashi, Kentaro Yamada, Kyo Noguchi, et al.. (2010). Isolation and characterization of novel human monoclonal antibodies possessing neutralizing ability against rabies virus. Microbiology and Immunology. 54(11). 673–683. 12 indexed citations
8.
Iwakiri, Dai, Li Zhou, Mrinal Samanta, et al.. (2009). Epstein-Barr virus (EBV)–encoded small RNA is released from EBV-infected cells and activates signaling from toll-like receptor 3. The Journal of Experimental Medicine. 206(10). 2091–2099. 240 indexed citations
9.
Hsiao, Jenn-Ren, Kung‐Chao Chang, Ih‐Jen Su, et al.. (2009). Endoplasmic Reticulum Stress Triggers XBP-1–Mediated Up-regulation of an EBV Oncoprotein in Nasopharyngeal Carcinoma. Cancer Research. 69(10). 4461–4467. 40 indexed citations
10.
Hino, Rumi, Hiroshi Uozaki, Noriko Murakami, et al.. (2009). Activation of DNA Methyltransferase 1 by EBV Latent Membrane Protein 2A Leads to Promoter Hypermethylation of PTEN Gene in Gastric Carcinoma. Cancer Research. 69(7). 2766–2774. 289 indexed citations
11.
Seto, Eri, Tadamasa Ooka, Jaap M. Middeldorp, & Kenzo Takada. (2008). Reconstitution of Nasopharyngeal Carcinoma–Type EBV Infection Induces Tumorigenicity. Cancer Research. 68(4). 1030–1036. 32 indexed citations
12.
Alajez, Nehad M., Joseph D. Mocanu, Wei Shi, et al.. (2008). Efficacy of Systemically Administered Mutant Vesicular Stomatitis Virus (VSVΔ51) Combined with Radiation for Nasopharyngeal Carcinoma. Clinical Cancer Research. 14(15). 4891–4897. 18 indexed citations
13.
Iwakiri, Dai, Mrinal Samanta, & Kenzo Takada. (2006). . Uirusu. 56(2). 201–208. 3 indexed citations
14.
Ahsan, Nazmul, Teru Kanda, Kazuo Nagashima, & Kenzo Takada. (2005). Epstein-Barr Virus Transforming Protein LMP1 Plays a Critical Role in Virus Production. Journal of Virology. 79(7). 4415–4424. 57 indexed citations
15.
Iwakiri, Dai & Kenzo Takada. (2004). Phosphatidylinositol 3-Kinase Is a Determinant of Responsiveness to B Cell Antigen Receptor-Mediated Epstein-Barr Virus Activation. The Journal of Immunology. 172(3). 1561–1566. 33 indexed citations
16.
Inoue, Hiroko, Kazuo Tsubota, Masafumi Ono, et al.. (2001). Possible Involvement of EBV-Mediated α-Fodrin Cleavage for Organ-Specific Autoantigen in Sjogren’s Syndrome. The Journal of Immunology. 166(9). 5801–5809. 36 indexed citations
17.
Takada, Kenzo. (2000). Epstein-Barr virus and gastric carcinoma. Molecular Pathology. 53(5). 255–261. 257 indexed citations
18.
Sugawara, Yasuhiko, Yuzo Mizugaki, Toshikazu Uchida, et al.. (1999). Detection of Epstein–Barr Virus (EBV) in Hepatocellular Carcinoma Tissue: A Novel EBV Latency Characterized by the Absence of EBV-Encoded Small RNA Expression. Virology. 256(2). 196–202. 81 indexed citations
19.
Wen, Shumin, Yuzo Mizugaki, Fumihiko Shinozaki, & Kenzo Takada. (1997). Epstein–Barr Virus (EBV) Infection in Salivary Gland Tumors: Lytic EBV Infection in Nonmalignant Epithelial Cells Surrounded by EBV-Positive T-Lymphoma Cells. Virology. 227(2). 484–487. 34 indexed citations
20.
Takada, Kenzo, et al.. (1991). An Epstein-Barr virus-producer line Akata: Establishment of the cell line and analysis of viral DNA. Virus Genes. 5(2). 147–156. 211 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026